Physician profile
Alexa Ives
NPI 1205492998
$6,807.06
in general payments reported to CMS, 2019-2025
19 companies · $1,107 in 2025
The $1,107 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $12.51 · 2021: $1,055 · 2022: $413 · 2023: $2,825 · 2024: $1,272 · 2025: $1,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,930 · Travel and Lodging: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,929.76 |
| Travel and Lodging | $1,274.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,908.51 | 2021-2025 | |
| Bausch & Lomb Americas INC. | $1,495.29 | 2022-2025 | Infuse, Miebo, Ultra Multifocal Toric |
| Coopervision INC. | $509.75 | 2023-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Visionary Optics LLC | $460.00 | 2021 | |
| Allergan, INC. | $414.20 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $391.58 | 2023-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $310.26 | 2021-2023 | Cequa |
| Alcon Vision LLC | $281.86 | 2024-2025 | Precision7, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $201.31 | 2019-2021 | |
| New World Medical,INC. | $192.25 | 2025 | Streamline, Via360, Clearpath |
| Tarsus Pharmaceuticals, INC. | $160.59 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $146.45 | 2023-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $125.32 | 2022-2023 | |
| Lkc Technologies, INC. | $107.48 | 2024-2025 | |
| Dompe US, INC. | $26.44 | 2024 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $23.40 | 2021 | |
| Abb Con-Cise Optical Group LLC | $18.15 | 2025 | Contact Lens, Spectacle Lenses |
| Maculogix, INC. | $17.28 | 2021 | |
| Abbvie INC. | $16.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Ives listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.